Explore Business Standard
DSM Anti Infectives (DAI), part of the Euro 9 billion DSM group, is entering into a manufacturing agreement with Mumbai based Arch Pharmalabs, a pharmaceutical major operating in the API and Intermediaries business for manufacturing of generic APIs. The company will leverage its world class innovation expertise to develop non infringing novel processes for various molecules. The company will then transfer these molecules to Arch Pharmalabs for commercial development.